EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus sp.: An In Silico Approach

Anna Merecz-Sadowska iD, Vera M S Isca, Przemysław Sitarek iD, Tomasz Kowalczyk iD, Magdalena Małecka iD, Karolina Zajdel, Hanna Zielińska-Bliźniewska, Mariusz Jęcek, Patricia Rijo iD, Radosław Zajdel

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25084529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Merecz-Sadowska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Molecular Dynamics Simulation, Plectranthus, Diterpenes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FCT—Fundação para a Ciência e a Tecnologia, PhD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diterpene 7α-acetoxy-6β-hydroxyroyleanone isolated from Plectranthus grandidentatus demonstrates promising antibacterial, anti-inflammatory and anticancer properties. However, its bioactivity may be enhanced via strategic structural modifications of such natural products through semisynthesis. The anticancer potential of 7α-acetoxy-6β-hydroxyroyleanone and five derivatives was analyzed in silico via the prediction of chemicals absorption, distribution, metabolism, excretion, and toxicity (ADMET), quantum mechanical calculations, molecular docking and molecular dynamic simulation. The protein targets included regulators of apoptosis and cell proliferation. Additionally, network pharmacology was used to identify potential targets and signaling pathways. Derivatives 7α-acetoxy-6β-hydroxy-12-O-(2-fluoryl)royleanone and 7α-acetoxy-6β-(4-fluoro)benzoxy-12-O-(4-fluoro)benzoylroyleanone achieved high predicted binding affinities towards their respective protein panels, with stable molecular dynamics trajectories. Both compounds demonstrated favorable ADMET parameters and toxicity profiles. Their stability and reactivity were confirmed via geometry optimization. Network analysis revealed their involvement in cancer-related pathways. Our findings justify the inclusion of 7α-acetoxy-6β-hydroxy-12-O-(2-fluoryl)royleanone and 7α-acetoxy-6β-(4-fluoro)benzoxy-12-O-(4-fluoro)benzoylroyleanone in in vitro analyses as prospective anticancer agents. Our binding mode analysis and stability simulations indicate their potential as selective inhibitors. The data will guide studies into their structure optimization, enhancing efficacy and drug-likeness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationMolecular Dynamics SimulationPlectranthusDiterpenesHumansAntineoplastic AgentsComputer SimulationAntineoplastic Agents, PhytogenicCell Proliferation

Stichwörter der Autor:innen

7α-acetoxy-6β-hydroxyroyleanonePlectranthus grandidentatusanticancer activity

Substanzen

DiterpenesAntineoplastic AgentsAntineoplastic Agents, Phytogenic7alpha-acetoxy-6beta-hydroxyroyleanone

Autor:innen und Institutionen

  • Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland.
  • Department of Allergology and Respiratory Rehabilitation, Medical University of Lodz, 90-725 Lodz, Poland.
  • Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisboa, Portugal.
  • Department of Medical Biology, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.
  • Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.
  • Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163/165, 90-236 Lodz, Poland.

ORCID-Profile: Anna Merecz-Sadowska, Przemysław Sitarek, Tomasz Kowalczyk, Magdalena Małecka, Patricia Rijo

Förderung

  • FCT—Fundação para a Ciência e a Tecnologia
  • PhD

Zitieren

APA

Merecz-Sadowska, A., Isca, V. M. S., Sitarek, P., Kowalczyk, T., Małecka, M., Zajdel, K., Zielińska-Bliźniewska, H., Jęcek, M., Rijo, P., & Zajdel, R. (2024). Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus sp.: An In Silico Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084529

Vancouver

Merecz-Sadowska A, Isca VMS, Sitarek P, Kowalczyk T, Małecka M, Zajdel K, et al. Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus sp.: An In Silico Approach. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084529

BibTeX
@article{MereczSadowska2024,
  author = {Merecz-Sadowska, Anna and Isca, Vera M S and Sitarek, Przemysław and Kowalczyk, Tomasz and Małecka, Magdalena and Zajdel, Karolina and Zielińska-Bliźniewska, Hanna and Jęcek, Mariusz and Rijo, Patricia and Zajdel, Radosław},
  title = {Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus sp.: An In Silico Approach},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25084529}
}
Kostenlos starten →